81
TITLE: An economic analysis of erlotinib, docetaxel, pemetrexed and best supportive care as second or third line treatment of non-small cell lung cancer  Full Text
AUTHORS: Araújo, A; Parente, B; Sotto-Mayor, R; Teixeira, E; Almodôvar, T; Barata, F; Queiroga, H; Pereira, C; Pereira, H; Negreiro, F; Silva, C;
PUBLISHED: 2008, SOURCE: Revista Portuguesa de Pneumologia (English Edition), VOLUME: 14, ISSUE: 6
INDEXED IN: CrossRef: 3
IN MY: ORCID
82
TITLE: Quantification of free circulating tumor DNA in plasma as a diagnostic marker for breast cancer  Full Text
AUTHORS: Ferreira, M; Catarino, R; Sousa, A; Rodrigues, H; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
83
TITLE: CYP3A5 polymorphism and NSCLC - a role for genetic variation as a protective factor in lung cancer susceptibility  Full Text
AUTHORS: Nogal, A; Coelho, A; Araujo, A; Catarino, R; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
IN MY: ORCID
84
TITLE: Genetic polymorphism of the epidermal growth factor gene-value for the treatment of non-small cell lung cancer (NSCLC)  Full Text
AUTHORS: Araujo, A; Araujo, AP; Teixeira, AL; Coelho, A; Ribeiro, R; Azevedo, I; Catarino, R; Pinto, D; Soares, M; Rui Medeiros ;
PUBLISHED: 2007, SOURCE: 14th European Cancer Conference (ECCO 14) in EJC SUPPLEMENTS, VOLUME: 5, ISSUE: 4
INDEXED IN: WOS CrossRef
IN MY: ORCID
85
TITLE: -2518 MCP-1 and interleukin-4 VNTR polymorphisms and NSCLC risk
AUTHORS: Ana P Coelho; Antonio Araujo; Carmen Calcada; Ana Nogal; Diana Cardoso; Ana Faria; Isabel Azevedo; Marta Soares; Raquel Catarino; Rui Medeiros;
PUBLISHED: 2007, SOURCE: JOURNAL OF THORACIC ONCOLOGY, VOLUME: 2, ISSUE: 8
INDEXED IN: WOS
86
TITLE: 6507 ORAL Phase III study of IV vinflunine (VFL) versus IV docetaxel (DTX) in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) previously treated with a platinum-containing regimen  Full Text
AUTHORS: J.Y Douillard; Coudert, B; Gridelli, C; Mohn-Staudner, A; Salzberg, B; Almodovar, T; Araujo, A; J.L Pujol; Riska, H; Depierre, A;
PUBLISHED: 2007, SOURCE: European Journal of Cancer Supplements, VOLUME: 5, ISSUE: 4
INDEXED IN: CrossRef
IN MY: ORCID
87
TITLE: Timomas malignos – A experiência do IPO do Porto e revisão da literatura
AUTHORS: Berta Sousa; António Araújo; Teresina Amaro; Isabel Azevedo; Marta Soares; Olga Sousa;
PUBLISHED: 2007, SOURCE: Revista Portuguesa de Pneumologia, VOLUME: 13, ISSUE: 4
INDEXED IN: CrossRef: 6
IN MY: ORCID
88
TITLE: P1-217: Retrospective study about using topotecan in second-line treatment of small-cell lung cancer. Experience of a single institution, from 2002 to 2006
AUTHORS: Ana Luísa L Faria; António Araújo; Marta Soares; Isabel Azevedo; José Leal da Silva;
PUBLISHED: 2007, SOURCE: Journal of Thoracic Oncology, VOLUME: 2, ISSUE: 8
INDEXED IN: CrossRef
IN MY: ORCID
89
TITLE: Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer
AUTHORS: Antonio M F Araujo; Jose C Mendez; Berta Sousa; Fernando Barata; Ana Figueiredo; Teresina Amaro; Ana Coelho; Isabel Azevedo; Marta Soares;
PUBLISHED: 2006, SOURCE: 30th Congress of the European-Society-for-Medical-Oncology in ANNALS OF ONCOLOGY, VOLUME: 17
INDEXED IN: WOS
Page 9 of 10. Total results: 93.